Variables | Number of women (%) | Â | Â | |
---|---|---|---|---|
In Discordant group (n = 189) | In Concordant group (n = 453) | p-value | ||
Age | Mean ± SD | 52.1 ± 11.3 | 52.2 ± 11.4 | 0.5861) |
Height (cm) | n | 158 (83.6%) | 391 (86.3%) | 0.3791) |
Unknown | 31 (16.4%) | 62 (13.7%) | ||
Mean ± SD | 158.7 ± 5.6 | 158.2 ± 6.0 | ||
Weight (kg) | n | 158 (83.6%) | 391 (86.3%) | 0.8671) |
Unknown | 31 (16.4%) | 62 (13.7%) | ||
Mean ± SD | 59.1 ± 9.6 | 59.4 ± 9.5 | ||
Anti-hypertensive medication | No | 156 (82.5%) | 374 (82.6%) | 0.9952) |
Yes | 33 (17.5%) | 79 (17.4%) | ||
Dyslipidemia medication | No | 164 (86.8%) | 396 (87.4%) | 0.8242) |
Yes | 25 (13.2%) | 57 (12.6%) | ||
Diabetes medication | No | 172 (91.0%) | 423 (93.4%) | 0.2932) |
 | Yes | 17 (9.0%) | 30 (6.6%) | |
Synthroid medication | No | 177 (93.7%) | 423 (93.4%) | 0.8982) |
Yes | 12 (6.4%) | 30 (6.6%) | ||
Other medication | No | 160 (84.7%) | 391 (86.3%) | 0.5832) |
Yes | 29 (15.3%) | 62 (13.7%) | ||
Breast density grade in mammograma | n | 84 (44.4%) | 185 (28.8%) | 0.8783) |
Unknown | 105 (55.6%) | 268 (41.7%) | Â | |
Grade 1 (Almost entirely fatty) | 3 (3.6%) | 4 (2.2%) | Â | |
Grade 2 (Scattered fibroglandular densities) | 11 (13.1%) | 24 (13.0%) | Â | |
Grade 3 (Heterogeneously dense) | 42 (50.0%) | 98 (53.0%) | Â | |
Grade 4 (Extremely dense) | 28 (33.3%) | 59 (31.9%) | Â | |
By site | 13 institutions | 189 (100%) | 453 (100%) | 0.3832) |